跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
1031
首页
药物
1031
1031
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Composition enriched in single isomer of NUC-1031 and preparation method and use thereof
US 10689413 B2
申请人: BRIGHTGENE BIO MEDICAL TECH CO LTD
优先权: 2015
CN
US
4 件公开
CRYSTALLINE FORM OF GEMCITABINE-(S)-PHOSPHATE DIASTEREOISOMER
EP 3725794 A1
申请人: NUCANA PLC
优先权: 2014
CN
EP
3 件公开
CANCER TREATMENTS
EP 3415149 A1
申请人: NUCANA PLC
优先权: 2015
CN
EP
3 件公开
US 11400107 B2
申请人: NUCANA PLC
优先权: 2016
CN
US
2 件公开
DIASTEREOSELECTIVE SYNTHESIS OF (SP)-GEMCITABINE-[PHENYL(BENZOXY-L-ALANINYL)]PHOSPHATE NUC-1031
EP 4011896 A1
申请人: NUCANA PLC
优先权: 2015
CN
EP
3 件公开
Combination therapy for cancer
US 10660912 B2
申请人: NUCANA PLC
优先权: 2015
CN
US
2 件公开
COMBINATION THERAPY
EP 3738595 A1
申请人: NUCANA PLC
优先权: 2015
CN
EP
2 件公开
CN 111295193 A
申请人: NUCANA PLC
优先权: 2017
CN
METHODS AND COMPOSITIONS FOR THE TREATMENT OF COVID-19 AND ASSOCIATED RESPIRATORY DISTRESS AND MULTI-ORGAN FAILURE, SEPSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND CARDIOVASCULAR DISEASES
US 2023248706 A1
申请人: ANN AND ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO
优先权: 2020
US
WO
2 件公开
ANTI-TUMOR ACTIVITY OF AECHL-1, NOVEL TRITERPENOID ISOLATED FROM AILANTHUS EXCELSA IN VITRO AND IN VIVO
US 2010311987 A1
申请人: NAT CT FOR CELL SCIENCE
优先权: 2008
US
Saccharin repaglinide amorphous material
CN 102321048 A
申请人: UNIV CHINA PHARMA
优先权: 2011
CN
一种化合物及其制备方法和其作物除草作用
CN 109111432 B
申请人: 潍坊科技学院
优先权: 2018
CN
第 1 / 2 页
上一页
下一页
药物
反馈